Answers by TheMediTary.Com - Last updated: 14-Jul-2023
Otezla was first approved for the treatment of psoriatic arthritis on March 21st, 2014 by the FDA and was on the market soon after (by the end of March 2014). Later that year, approval was granted for using Otezla for moderate to severe psoriasis (Sept 23, 2014), and a few years later, for oral ulcers associated with Behçet's disease (July 19, 2019). Otezla is made by Amgen Inc, located in Thousand Oaks, California.